The research team, led by Abeya Fufa Worke of Mattu University together with colleagues from the university’s departments of midwifery and nursing, reviewed the medical records of 512 newborns admitted with sepsis to the hospital’s Neonatal Intensive Care Unit between January 2022 and December 2023. The two-year window captured a broad cross-section of cases in a region where specialized neonatal care is scarce and every day of hospitalization carries both clinical and economic weight for families.

The headline result is strikingly encouraging. Of the 512 neonates included in the final analysis, 497, or 95.2 percent, recovered from their infection. The median time to recovery was just six days, with an interquartile range of five to seven and a half days, meaning half of the surviving newborns were well enough to leave intensive care within roughly a week of admission. For a hospital operating in a resource-constrained corner of Southwest Ethiopia, those numbers suggest that the NICU’s standard care pathway is working.

But the study’s deeper contribution lies in its statistical machinery. Rather than simply comparing averages, the researchers deployed survival analysis techniques, beginning with Kaplan-Meier curves to visualize how recovery probability changed day by day, and then fitting a Weibull regression model to identify which clinical characteristics independently accelerated or delayed recovery. The Weibull distribution, a flexible parametric approach, is particularly well suited to time-to-event data like hospital recovery, where the hazard of recovery can rise or fall over the course of illness. Model selection was guided by the Akaike and Bayesian Information Criteria, and the team checked for multicollinearity using variance inflation factors, a level of methodological rigor that strengthens confidence in the final estimates.

The regression model surfaced a cluster of clinical predictors associated with slower recovery. Newborns presenting with leukopenia, an abnormally low white blood cell count, took longer to recover, a biologically plausible finding since a depleted immune cell arsenal limits the body’s capacity to clear infection. Respiratory distress and apnea, the latter referring to pauses in breathing that are common and dangerous in septic newborns, also predicted prolonged recovery, as did poor feeding, which can compound weakness and delay the return to normal growth.

Two additional factors stood out. Late-onset sepsis, defined as infection occurring between the eighth and twenty-eighth days of life, was linked to slower recovery compared with early-onset disease acquired within the first week. And newborns who received a clinical diagnosis of meningitis, an infection of the membranes surrounding the brain, faced a markedly longer road back to health. Meningitis in the neonatal period is notoriously difficult to treat, as antibiotics must penetrate the blood-brain barrier, and it often signals a more severe or disseminated infection.

The distinction between early-onset and late-onset sepsis carries practical implications. Early-onset infections typically stem from organisms acquired from the mother during delivery, while late-onset cases more often arise from the hospital or community environment. The finding that late-onset disease predicts slower recovery underscores the importance of infection prevention measures within NICUs themselves, from rigorous hand hygiene to careful management of invasive devices, as well as prompt recognition of illness in babies who have already gone home.

For clinicians working under the World Health Organization’s Integrated Management of Neonatal and Childhood Illness framework, the study offers a practical triage signal. A newborn with sepsis who also shows respiratory distress, apnea, poor feeding, or low white blood cell counts is not just sicker on arrival but statistically likely to occupy a NICU bed longer. Anticipating that trajectory could guide earlier escalation of care, closer monitoring, and more proactive nutritional support, potentially shaving critical days off recovery time.

The authors are careful to frame the findings within the limits of a retrospective, record-based design. Because the analysis relied on de-identified medical records rather than prospective follow-up, the predictors reflect associations observed in routine clinical documentation, and the diagnosis of meningitis was made clinically rather than confirmed by lumbar puncture in every case. The ethics committee of Mattu University’s Institutional Health Research Ethics Review Committee approved the study under the Declaration of Helsinki and formally waived individual informed consent given the retrospective use of de-identified data.

Even with those caveats, the study delivers a message of cautious optimism. A 95.2 percent recovery rate and a median stay of six days indicate that effective neonatal sepsis care is achievable far from the well-resourced hospitals of high-income countries. The path forward, the researchers conclude, lies in targeting the specific complications that slow recovery, particularly respiratory problems, meningitis, and feeding difficulties. For the thousands of Ethiopian families whose newborns face this infection each year, closing that gap could mean the difference between a one-week scare and a far longer, more dangerous ordeal.

Subject of Research: Time to recovery and predictors of neonatal sepsis in a Southwest Ethiopian neonatal intensive care unit

Article Title: Time to recovery and predictors of neonatal sepsis in Southwest Ethiopia, 2024

Article References: Balcha, M. L., Worke, A. F., Tesfaye, H., & Bidira, K. (2026). Time to recovery and predictors of neonatal sepsis in Southwest Ethiopia, 2024. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14576-w

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14576-w

Keywords: neonatal sepsis, Ethiopia, recovery time, survival analysis, Weibull regression, Kaplan-Meier, NICU, leukopenia, apnea, respiratory distress, meningitis, late-onset sepsis

The research, published in Nursing Open, evaluated a 12-element tracheostomy care bundle adapted from an evidence-based guideline and delivered entirely by trained critical care nurses. The bundle operationalizes tracheostomy management through continuous physiological surveillance, scheduled suctioning, humidification, cuff pressure monitoring, structured stoma assessment, oral care, tube security checks, emergency equipment readiness, resuscitation preparedness, mobilization, and standardized documentation with defined escalation criteria. Crucially, each element was designed to target a specific mechanism of harm rather than to function as a generic checklist. Inadequate suctioning permits secretion accumulation and airway obstruction; unmonitored cuff pressure predisposes patients to mucosal injury and leak-related aspiration; inconsistent stoma assessment delays detection of local infection; and insufficient humidification promotes mucus plugging. Because each of these failure points is nursing-sensitive, the researchers argued that a structured, nurse-led response was needed to interrupt the complication pathway.

The study recruited 80 critically ill adult patients with tracheostomies, divided equally between a control cohort receiving routine care and an intervention cohort receiving the bundle. Allocation followed a sequential temporal design: all consecutive eligible patients admitted between January and April 2025 received routine care, while those admitted between June and September 2025, after a four-week nurse training program, received the bundle. This pragmatic approach prevented contamination between groups during staff education but, as the authors acknowledge, meant that participants were not randomly assigned, leaving open the possibility of selection bias. Six participants were lost during follow-up and replaced to maintain the planned sample size, and no adverse events directly attributable to the bundle were observed.

Outcomes were tracked with a battery of validated instruments applied at baseline, one week, and two weeks after tracheostomy insertion, or until discharge. The National Early Warning Score (NEWS) integrated seven physiological parameters, including respiratory rate, oxygen saturation, temperature, blood pressure, heart rate, and consciousness level, to detect clinical deterioration. The Respiratory Distress Observation Scale (RDOS) captured eight observable indicators of breathing difficulty, from accessory muscle use to facial expressions of fear, in patients too sedated or ventilated to report dyspnea themselves. A modified Clinical Pulmonary Infection Score (CPIS), excluding microbiological culture because results were not consistently available within 24 to 48 hours, screened for suspected respiratory infection. Inter-rater reliability testing during a pilot phase showed good agreement between independent assessors, with intraclass correlation coefficients of 0.82 for NEWS, 0.88 for RDOS, and 0.87 for the modified CPIS.

The results on stoma integrity were striking. At baseline, immediately after insertion, no patient in either group showed local abnormalities. By one week, however, the control group had begun to accumulate complications: 27.5 percent showed purulent discharge and 32.5 percent foul-smelling drainage, compared with 10.0 percent and 7.5 percent respectively in the bundle group. By two weeks, the gap widened further, with significant differences in redness, warmth around the stoma, and foul-smelling drainage. The overall stoma-integrity composite score averaged 0.80 in the intervention group at one week versus 1.85 in controls, and 0.43 versus 1.33 at two weeks. A longitudinal repeated-measures model confirmed a significant Group by Time interaction, meaning the two cohorts followed genuinely different trajectories rather than merely differing at a single snapshot.

Respiratory distress told a similar story. At baseline, roughly nine in ten patients in both groups showed no distress on the RDOS. At one week, 52.5 percent of bundle patients remained free of distress compared with just 10.0 percent of controls, and moderate or severe distress was concentrated in the routine-care group. At two weeks, 77.5 percent of intervention patients had no distress versus 47.5 percent of controls. The repeated-measures model again found a significant Group by Time interaction, indicating a steeper longitudinal reduction in distress among bundle recipients. The researchers attribute this to bundle components targeting airway patency, secretion management, and humidification, which allow earlier recognition and correction of airway problems before they escalate into overt respiratory compromise.

Physiological stability, measured through daily NEWS assessments over 15 days, also favored the intervention. Baseline risk categories were comparable between groups, but on days three and nine the bundle group had significantly fewer high-risk patients. Discharge patterns diverged even more dramatically: by day 11, 42.5 percent of intervention patients had achieved clinical stability and been discharged, compared with only 5.0 percent of controls, and by day 14 the figures were 60.0 percent versus 32.5 percent. The authors caution that discharge status was treated as a separate endpoint from NEWS classification, but the overall pattern points toward a faster transition to physiological stability under structured care.

One anticipated benefit did not materialize with statistical significance. Suspected early-onset respiratory infection at one week occurred in 20.0 percent of controls and 10.0 percent of bundle patients, and suspected late-onset infection at two weeks occurred in 10.0 percent versus 5.0 percent. The direction favored the intervention, but the differences did not reach significance, and the researchers are explicit that these findings should not be interpreted as evidence of a confirmed reduction in pneumonia. They point to the relatively small sample, the limited 15-day follow-up, and the absence of microbiological confirmation within the modified CPIS as constraints. Infection outcomes, they note, are shaped by baseline illness severity, ventilation duration, and colonization status, factors that nursing interventions alone may not fully modify and that may require longer observation and larger cohorts to detect meaningful change.

The study’s limitations deserve careful weight. Beyond the non-randomized design and the resulting risk of unmeasured confounding, blinding of bedside nurses was unfeasible for such a complex nursing intervention, leaving observational endpoints like stoma assessment and RDOS scoring susceptible to detection bias despite standardized criteria. Intervention fidelity was maintained through real-time supervision but was not quantified as a numerical adherence percentage, so the dose-response relationship across the 12 elements could not be measured. The single-center setting and localized ICU population also constrain generalizability, and the 15-day window precluded evaluation of decannulation success, late airway complications, or long-term infection dynamics.

Nevertheless, the findings carry practical weight for intensive care units everywhere. The clearest effects appeared on outcomes most directly tied to daily nursing practice, stoma-site management, respiratory monitoring, and early physiological assessment, suggesting that structured bundles work precisely where nurses work. The authors recommend incorporating the bundle into quality-improvement frameworks with standardized protocols, bedside checklists, documentation tools, and competency-based training, while calling for larger multicenter randomized trials with blinded assessors, microbiological confirmation, and quantitative fidelity tracking. Until such trials arrive, the study offers a compelling signal that empowering nurses with a systematic, evidence-based framework for tracheostomy care can translate into fewer wound complications, calmer breathing, and earlier stability for some of the most vulnerable patients in the hospital.

Subject of Research: Effect of a nurse-led tracheostomy care bundle on stoma integrity, respiratory distress, and pneumonia-related outcomes in critically ill ICU patients

Article Title: Impact of a 12‐Element Nurse‐Led Tracheostomy Care Bundle on Stoma Integrity, Respiratory Distress and Suspected Pneumonia‐Related Outcomes Among Patients With Tracheostomies: A Quasi‐Experimental Study

Article References: Hammouda, E. Y., Zaky, M. E., Ahmed, M. S. A., Zahran, W. E.-K., & Mansour, H. E.-S. (2026). Impact of a 12‐Element Nurse‐Led Tracheostomy Care Bundle on Stoma Integrity, Respiratory Distress and Suspected Pneumonia‐Related Outcomes Among Patients With Tracheostomies: A Quasi‐Experimental Study. Nursing Open, 13(10), Article e70861. https://doi.org/10.1002/nop2.70861

Image Credits: AI Generated

DOI: 10.1002/nop2.70861

Keywords: tracheostomy, nursing care bundle, intensive care, stoma integrity, respiratory distress, pneumonia, NEWS score, RDOS, CPIS, quasi-experimental study, patient safety, Egypt

The biological premise behind the device is elegant. Fetal skin does not mature in a linear fashion; instead, it follows a sigmoid trajectory, meaning that its structure and composition change dramatically and predictably across the course of gestation. As the fetus approaches term, the skin’s maturation alters the way it reflects light. A noninvasive optical sensor can detect these shifts in reflectance and translate them into an estimate of gestational age. Because the measurement is passive, painless, and requires no blood draw, no imaging equipment, and no specialized operator, it is precisely the kind of technology that could function in a birth center with no physician on site, or in a boat-accessed village where the nearest ultrasound machine is hundreds of kilometers away.

Why does gestational age matter so much? The answer, according to the research team led by Roberta Lins Gonçalves of the Federal University of Amazonas, lies largely in the respiratory system. Gestational age is the single most important factor for stratifying a newborn’s early respiratory risk. Babies born significantly preterm are at elevated risk of respiratory distress syndrome, a condition in which underdeveloped lungs lack sufficient surfactant and struggle to keep the air sacs inflated. Knowing whether a newborn is 32 weeks or 37 weeks along changes everything about how clinicians triage that infant: whether to monitor closely, whether to transfer to a neonatal intensive care unit, whether to prepare ventilatory support. Yet in resource-poor settings, the gold standard for dating a pregnancy, a first-trimester obstetric ultrasound, is often unavailable or unreliable, and the date of the last menstrual period is frequently uncertain or misremembered.

The APPLE study, whose name derives from the Portuguese phrase Acompanhamento de Bebês pelo PreemieTest, meaning follow-up of babies using the PreemieTest, will enroll newborns across a strikingly diverse network of birth settings in Brazil and Honduras. Participating sites include the Getúlio Vargas University Hospital in Manaus, the Sofia Feldman Hospital in Belo Horizonte, the Maria Aparecida Pedrossian University Hospital and the Florescer Humanized Birth Center in Mato Grosso do Sul, the Januário Cicco Maternity School and Ana Bezerra University Hospital in Rio Grande do Norte, and, crucially, the Vó Mundoca Hospital in Borba and the Edith Mendes Weckner Hospital in Novo Aripuanã, both riverside and remote municipalities in the Amazon. In Honduras, the study spans Hospital Escuela, the Instituto Hondureño de Seguridad Social, and Hospital General San Felipe in Tegucigalpa. This deliberate spread across tertiary hospitals, maternity schools, birth centers, and remote communities is the point: the researchers want to know not whether the device works in an idealized laboratory, but whether it works everywhere a baby might actually be born.

Methodologically, the validation is rigorous and multipronged. The gestational age estimated by PreemieTest will be compared against three traditional reference approaches: first-trimester ultrasound when available, which the researchers treat as the gold standard; the date of the last menstrual period; and a postnatal clinical score, a standardized assessment based on physical and neurological signs of maturity. Agreement between the device and these references will be quantified using correlation coefficients, Bland–Altman plots, which reveal whether a device systematically overestimates or underestimates across the measurement range, and concordance analyses. The team will also report the mean absolute error, a clinically intuitive metric that expresses, in weeks, how far off the device typically is. Performance will be examined across different skin phototypes, a critical consideration in a study population spanning the wide range of skin tones found in Brazil and Honduras, where pigmentation could plausibly influence optical readings if the algorithm were not properly calibrated.

What sets this study apart from a typical device-validation exercise is its longitudinal ambition. The researchers will follow the infants and model respiratory outcomes, including hospitalizations, clinical diagnoses, and the use of ventilatory support, at birth, three months, and six months of age. Using multivariable logistic regression adjusted for prespecified confounders such as birth weight, sex, prematurity, mode of delivery, and ultrasound-based gestational age, and accounting for clustering by study location, they aim to determine whether the device’s gestational age estimates actually predict clinically meaningful outcomes. This is the difference between a device that produces a number and a device that changes care. If optical gestational age assessment stratifies respiratory risk as well as ultrasound dating does, the case for deployment in low-resource settings becomes compelling.

The protocol also takes usability seriously, which is often the Achilles heel of medical devices intended for frontline use. Midwives, who in many of the participating settings are the primary birth attendants, will rate the device using the System Usability Scale, a validated instrument that yields a standardized score of perceived ease of use. A device that is accurate but cumbersome will simply not be adopted in a busy maternity ward or a community health post. By measuring usability alongside accuracy, the APPLE study is effectively testing the entire implementation pathway, not just the sensor. The study is registered in the Brazilian Clinical Trials Registry under RBR-10ch623r, was approved by ethics committees at all participating institutions in both countries, and will be conducted in accordance with the Declaration of Helsinki, with written informed consent obtained from parents or legal guardians.

Data management reflects a similarly careful design. All information will be captured in Research Electronic Data Capture, the widely used REDCap platform, with standardized quality checks and continuous monitoring for completeness. Missing data, an inevitable feature of any study spanning the Amazon to urban Honduras, will be handled through multiple imputation and sensitivity analyses, so that the conclusions are robust to realistic imperfections in follow-up. The study is funded by Birthtech Dispositivos para a Saúde, the device’s manufacturer, together with Grand Challenges Canada, and supported by Brazilian federal agencies including CAPES, CNPq, and the Amazonas Research Foundation, a funding mix that pairs commercial development with public health philanthropy.

The stakes are enormous. The World Health Organization has long identified prematurity as the leading cause of death in children under five, and the first step in managing a preterm infant is knowing that the infant is preterm. In settings where early ultrasound is a luxury, clinicians currently rely on last menstrual period recall and postnatal scoring, both of which carry substantial error. A low-cost, handheld optical device that delivers a reliable gestational age estimate in the first day or two of life, across skin tones and across levels of care, would give midwives and physicians in the most remote corners of the world the same dating information that wealthy health systems take for granted. The APPLE study will not deliver that answer until its results are in, but its protocol, spanning the Amazon’s river communities to Tegucigalpa’s teaching hospitals, shows what honest, real-world validation of a global health technology looks like: diverse sites, hard reference standards, longitudinal outcomes, and a willingness to test whether a promising gadget survives contact with the places that need it most.

Subject of Research: Post-market validation of a portable optical device for newborn gestational age assessment

Article Title: APPLE study protocol: post-market validation of the PreemieTest® device for gestational age assessment in diverse birth settings

Article References: Gonçalves, R. L., da Costa Neto, S. S., de Souza, E. K. S., da Silva, A. V., Soares-Marangoni, D., Zambrano, L. I., Neves, G. S., Miralha, A. L., Lopes, T. C. P., de Andrade Vieira, J. A. R., da Silva, A. V., Costa, A. J. T., Lima, E. C. C., Bessa, N. B., Bahia, B. L., de Souza Rocha, P. G., de Sousa Júnior, F. S., Lima, J. C. B., Lima, H. L. O., … Pereira, S. A. (2026). APPLE study protocol: post-market validation of the PreemieTest® device for gestational age assessment in diverse birth settings. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07640-6

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07640-6

Keywords: gestational age, PreemieTest, prematurity, neonatal care, skin reflectance, optical device, Brazil, Honduras, Amazon, respiratory distress, global health, study protocol